Exciting discussion on Enterprise Resource Planning systems now live at 20/20 Pharma

June 21, 2011 - PRLog -- Industry experts go head to head in 20/20 Pharma’s ‘Making a sound investment in ERP’ podcast discussion. Join leaders in this discussion covering the fundamental points of Enterprise Resource Planning systems. The podcast is available to download free at:

http://www.2020pharma.com/podcast/making-sound-investment-erp

Facilitating the in-depth conversation is Reid Graves, Merck’s Senior Business Process Lead for SAP Supply Chain Master Data, who is joined by three industry experts: Trevor Miles of Kinaxis, Joe Miles of SAP and Tom Heinricher of Sage.

The podcast is an insightful analysis of Enterprise Resource Planning systems and includes comments on:
-   Key business areas in ERP solutions
-   Global instances of the ERP system
-   Costs associated with outsourcing operations that limit visibility
-   Key areas where ERP systems fall short
-   Other software systems used to augment the ERP system
-   Advice for companies seeking to implement ERP systems

In the podcast Tom Heinricher said: “Companies are always looking for reasons to improve their business processes and typically they are pursuing solutions that are associated with automation or streamlining of their work flows.

He also commented: “What we constantly see, specifically in the pharma industry, is businesses often purchase ERP solutions that can provide truly global solutions and they’re looking to integrate end-to-end processes.

In the podcast Trevor Miles also said: “When you move into systems of innovation, this is where we see lots of people struggling with a notion of a single instance because so much of the supply chain exists outside the organization – by default often outside that single instance of the ERP.”

For more information and topical pharmaceutical related podcasts visit www.2020pharma.com.

About 20/20 Pharma
20/20 Pharma is a product of IMI Publishing Ltd, dedicated to offering its clients and partners a unique opportunity to not only advertise the capabilities of their companies, but also showcase their technology or services through in-depth educational pieces and targeted online events.
Dedicated to being a trusted and authoritative resource within top pharmaceutical companies, as well as small, specialty and biotech businesses, 20/20 Pharma bridges the gap between the industry’s top issues and the solutions that top-tier vendors can provide.

Contact details
Pinar Gencturk
Managing Editor, 20/20 Pharma
+44 207 148 5152 | pgencturk@imipublishing.com

# # #

20/20 Pharma, published by IMI, is a magazine which presents insightful analysis of current events, developments, and trends in the pharmaceutical world.